The Founder and Chairman of Uscom, Professor Rob Phillips put out an email to the media recently in which he claimed the company was 63% undervalued despite continued share price growth over the past 8 years.. This was based on Simply Wall Street’s algorithmic valuation system.

From email:

As a result I was keen to discuss the issue in more detail and in my a interview with Prof. Philips, he expressed his confusion as to why the company is currently trading at virtually the same price it was 8 years ago, despite having achieved a siginifcant amount, in terms of product development., sales and market penetration- not to mention revenue growth and profitability.

About USCOM:

The company was founded in 2000 on translational cardiovascular research by Associate Professor Rob Phillips at the University of Queensland. Uscom has sold over 1000 1A units into leading hospitals and clinics worldwide.

Since then Uscom has acquired what it calls “practice changing” and “complimentary non-invasive cardiovascular and pulmonary technologies.” Uscom acquired Pulsecor Limited in 2013, and Thor Laboratories in 2015.

Uscom are the experts in circulation delivering, non-invasive cardiovascular and pulmonary monitoring devices.

Uscom markets the USCOM 1A advanced hemodynamic monitor, the BP+ and BP+ Reporter, and SpiroSonic digital ultrasonic spirometer series and the proprietary SpiroReporter software. These devices are changing the way cardiovascular and pulmonary medicine is practiced. Uscom has sold over 1000 1A units into leading hospitals and clinics worldwide.

Uscom claims abundant IP and a strong product pipeline projecting well into the next 10 years. Visit their website here.

USCOM FINANCIALS AND MARKET SIZE:

Operations Sydney Singapore Beijing Budapest Offices Auckland London LA.

Sale of Goods $2.30M up 232%*

Revenue and Income $2.77M up 187%*

Receipts from Customers $2.81M up 153%*

Net cash flow up $1.14M*

CY20 Revenue and Income $6.09M up 95% from $3.12M*

CY20 Cash $2.3M up $0.8M pa*

Claims to be China embedded, globally diversified and poised for growth, and hedged for politics and currency.

*H1 FY21 Investor Presentation